Health & Nutrition

Themenbereich / / Health & Nutrition


Sortiere PresseMitteilungen nach: Titel (A\D) Datum (A\D)

Seiten sind aktuell sortiert nach: Datum (erst neue PresseMitteilungen)

Immunotec Enters Into Agreement to Be Acquired

VAUDREUIL-DORION, QUEBEC -- (Marketwired) -- 03/22/17 -- Immunotec Inc. (TSX VENTURE: IMM) ("Immunotec" or the "Company") announced today that it has entered into a definitive agreement (the "Arrangement Agreement") with 1111267 B.C. Ltd., a subsidiary of Immuno Holding S.A. de C.V. ("Immuno Holding"), pursuant to which Immuno Holding is expected to acquire all of the issued and outstanding common shares of the Company ("Shares") for a cash consideration of $0.485 per Share (the "Transaction"). The consideration represents a premium ...

22.03.2017

Immunotec Provides an Update on Taxation Matters in Mexico

VAUDREUIL-DORION, QUEBEC -- (Marketwired) -- 03/21/17 -- Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"), announced today that it has received a ruling from the Mexican Tax Administration Services (MTAS) confirming that its Immunocal MX and Immunocal Platinum products should be classified for importation purposes in HTS code 2106.10.99, the code originally used by the Company prior to August 2013. This milestone is a positive step towards the resolution of the importation audit matters ...

21.03.2017

IntelGenx to Report Fourth Quarter and Full Year 2016 Financial Results on March 28, 2017 - Conference Call to Follow

SAINT-LAURENT, QUEBEC -- (Marketwired) -- 03/21/17 -- IntelGenx Technologies Corp., (TSX VENTURE: IGX)(OTCQX: IGXT), today announced that it will release its fourth quarter and full year 2016 financial results after market close on March 28, 2017.An accompanying conference call will be hosted by Dr. Horst G. Zerbe, President and Chief Executive Officer and Mr. Andre Godin, Executive Vice-President and Chief Financial Officer, to discuss the results and provide a business update. Details of the conference call and webcast are below:Date: Tuesday, March 28, 2017Time: 4:30 p.m. ETConference dial ...

21.03.2017

Nephros Reports 2016 Fourth Quarter and Full Year Financial Results and Provides Corporate Update

RIVER EDGE, NJ -- (Marketwired) -- 03/20/17 -- Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration ("HDF") system for use with a hemodialysis machine for the treatment of patients with end stage renal disease, announced today financial results for the three months and full year ended December 31, 2016."In 2016, we continued to execute on our growth strategy, focusing on the expansion of our product portfolio and on ...

20.03.2017

San Diego Dentist Expands Office Space to Better Serve Patients

SAN DIEGO, CA -- (Marketwired) -- 03/16/17 -- Building upon her mission to provide state-of-the-art dental care, Cathy Santone, DDS has announced the completion of a new office expansion for Encinitas Cosmetic Dentistry. The highlights that this additional space will house exciting new dental equipment and technology as well as four extra operatories to better serve patients. The modern environment was designed with patient comfort and safety in mind, and Dr. Santone believes this expansion will further enhance quality of care.Encinitas Cosmetic Dentistry has always prioritized holistic dent ...

16.03.2017

IntelGenx Engages Kilmer Lucas for Cross-Border Investor Relations

SAINT-LAURENT, QUEBEC -- (Marketwired) -- 03/13/17 -- IntelGenx Technologies Corp. (TSX VENTURE: IGX)(OTCQX: IGXT) ("IntelGenx" or the "Company") today announced that it has retained Kilmer Lucas Inc. ("Kilmer Lucas") to provide the Company with select Canadian and U.S. investor relations ("IR") and strategic advisory services.Employing an "outsourced in-house" partnership model, Kilmer Lucas designs and executes customized IR programs for medical device, drug development, cell therapy, diagnostics and healthcare services companies."As I ...

13.03.2017

First Choice Healthcare Solutions Welcomes Board Certified Orthopaedic and Spine Surgeon Dr. James Billys to The B.A.C.K. Center

MELBOURNE, FL -- (Marketwired) -- 03/08/17 -- (OTCQB: FCHS) ("FCHS," "First Choice" or the "Company"), one of the nation''s only non-physician-owned, publicly traded healthcare services companies focused on the delivery of total musculoskeletal solutions with an emphasis on Orthopaedics, including spine care and treatment, is pleased to announce that James B. Billys, M.D. has joined the medical staff at The B.A.C.K. Center ("TBC") where he will specialize in minimally invasive spine surgery.Dual board certified in Orthopaedic Surgery and Surg ...

08.03.2017

Tauriga Sciences, Inc. Notified by Federal District Court New Jersey of April 17, 2017 Trial Status Conference

NEW YORK, NY -- (Marketwired) -- 03/07/17 -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or "the Company"), a company engaged in building businesses in the life sciences space, has today provided its shareholders with an update on the status of its ongoing federal lawsuit against its predecessor audit firm Cowan Gunteski & Co. PA ("Cowan Gunteski"). This case is titled "Tauriga Sciences, Inc. v. Cowan, Gunteski & Co., P.A. et al" and is being tried in Federal District Court of New Jersey (the "Court"); Case No. 15-CV-62334.A Tri ...

07.03.2017

Nephros Receives FDA 510(k) Clearance of EndoPur(TM) Endotoxin 10" Filter

RIVER EDGE, NJ -- (Marketwired) -- 03/06/17 -- Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration ("HDF") system for use with a hemodialysis machine for the treatment of patients with end stage renal disease, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") to market its EndoPur™ Endotoxin 10" Filter.The EndoPur™ Endotoxin 10" Filter is designed ...

06.03.2017

Bodybuilding - Leading 7 Ideas to Achieve Muscle Quick

Listed below are some top rated recommendations for muscle building that you really should know should you want genuine final results with your education. After all, you go to the gym but you also desire to get benefits for your efforts that you can see and others can appreciate. The top strategies are: 1. Use a successful exercise routine for bodybuilding. You may discover these on the web for example Shawn LeBrun''s get ripped exercise, Optimum Anabolics or Hugo Riviera''s exercise plans. 2. Do not overtrain - Overtraining refers to training for too several hours a ...

05.03.2017

VPR Brands will be participating at the SE Petro-Food Marketing Expo

FORT LAUDERDALE, FL -- (Marketwired) -- 03/03/17 -- VPR Brands, LP (OTC PINK: VPRB) is proud to be a part of the 2017 SE Petro-Food Marketing Expo in Myrtle Beach, SC Wednesday, March 8-9th. The Company will showcase VAPORIN, it''s national convenience store Electronic Cigarette brand at booth# 1615. Vaporin''s innovative technology offers the look, feel and taste of traditional smoking, but without the tar, tobacco, ash, smoke, or odor. Vaporin offers a variety of vaporizer''s and e-liquids focused toward the Convenience customer."Vaporin has one of the mor ...

03.03.2017

Global Biodegradable Stents Market to Grow steadily with a Strong CAGR of 30.1% through 2024

Albany, New York, March 2, 2017: In recent times, increasing prevalence of coronary and peripheral artery diseases has become a key driver of the rapidly increasing global biodegradable stents market. Also, the effectiveness of biodegradable stents has won the market several consumers in the recent past. Consequently, numerous patients and cardiologists have shown a strong interest in the uptake of biodegradable stents in the cure of coronary and peripheral artery diseases. This has been observed by a fresh study published to the online archive of Market Research Hub (MRH). The study is entitl ...

02.03.2017

Washington, DC Eye Doctor First in Area to Place CyPass Glaucoma Implant

WASHINGTON, DC -- (Marketwired) -- 03/01/17 -- Eye Doctors of Washington glaucoma specialist Dr. Hylton Mayer recently performed the first CyPass® glaucoma implant placement for glaucoma patients with cataracts in the DC metro area. In placing the CyPass® device, and utilizing other novel glaucoma treatments, Dr. Mayer and his partner Dr. Ken Schor, board-certified and fellowship-trained glaucoma specialists at Eye Doctors of Washington, continue their commitment to pursue safe and effective interventions for patients with cataracts and glaucoma.A cataract is a clouding of the lens in the ey ...

01.03.2017

Ogilvy CommonHealth Worldwide''s Michael Zilligen to speak at the Advertising and Promotion Regulatory Affairs Conference

PARSIPPANY, NJ -- (Marketwired) -- 02/23/17 -- Ogilvy CommonHealth Worldwide (), the health behavior change specialists of Ogilvy & Mather (), and a WPP Health & Wellness company (NASDAQ: WPPGY) (), today announced Michael Zilligen, president of Ogilvy CommonHealth Payer Marketing and Ogilvy Healthworld Payer Marketing, has been selected to speak at the Advertising and Promotion Regulatory Affairs Conference taking place February 23 and 24 in Washington, DC.The Advertising and Promotion Regulatory Affairs Conference, presented by the Drug Information Association, takes a deeper look a ...

23.02.2017

Ogilvy CommonHealth Worldwide''s Baranello and Vidal Inducted Into the Medical Advertising Hall of Fame''s Future Famers Program

PARSIPPANY, NJ -- (Marketwired) -- 02/23/17 -- Ogilvy CommonHealth Worldwide (), the health behavior change specialists of Ogilvy & Mather (), and a WPP Health & Wellness company (NASDAQ: WPPGY) (), today announced Jigna Baranello, VP, account group supervisor, and Ana Maria Vidal, account executive, were both named to the Medical Advertising Hall of Fame''s (MAHF) fifth annual Future Famers Program at last night''s awards dinner held at the Pierre Hotel in New York City.Over the past decade, the MAHF has recognized those individuals who have made a lasting mark on ...

23.02.2017

Nephros to Present at the SeeThruEquity 3nd Annual Innovations Investor Conference on Feb. 22, 2016

RIVER EDGE, NJ -- (Marketwired) -- 02/16/17 -- Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal Disease (ESRD), will present at the SeeThruEquity 3nd Annual Innovations Investor Conference at The W Hotel in Miami on South Beach on February 22, 2017.Company President and CEO Daron Evans will provide a 30-minute overview of the busi ...

16.02.2017

Immunotec Reports Record-Breaking Convention Attendance for its "Brand Evolution" Launch

VAUDREUIL-DORION, QUEBEC -- (Marketwired) -- 02/16/17 -- Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"), launched a comprehensive brand identity update including new packaging for its flagship products, Immunocal® and Immunocal® Platinum, in twin events held in Long Beach, California, and Mexico City at the beginning of February. The two events were attended by almost 4,000 independent Consultants, marking the highest Convention attendance in the Company''s history.The eleme ...

16.02.2017

Nephros Announces Appointment of Andrew Astor as Chief Financial Officer

RIVER EDGE, NJ -- (Marketwired) -- 02/14/17 -- Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal Disease (ESRD), announced today that it had hired Andrew Astor as Chief Financial Officer."We are very pleased to have Andy join the Nephros team," said Daron Evans, Chief Executive Officer of Nephros. "Andy brings a weal ...

14.02.2017

Electronic Cigarette - The following Quit Smoking Device

Ever since the public became conscious in regards to the dangers of smoking several decades ago, lots of individuals have located quitting the tobacco habit hard. Corporations have already been innovating and manufacturing smoking cessation products for a lot of years now. From nicotine patches to gum, nicotine addicts happen to be utilizing them to quit their habit. Electronic cigarettes (also called e-cigarettes and electric cigarettes)are the newest product out there. They''re designed to appear and really feel like real cigarettes, even down to emitting artificial smoke howev ...

09.02.2017

IntelGenx and Tetra Bio-Pharma Announce the Signing of a Term Sheet for the Development and Commercialization of a Dronabinol XL Tablet

SAINT-LAURENT, QUEBEC -- (Marketwired) -- 02/09/17 -- IntelGenx Corp. ("IntelGenx"), (TSX VENTURE: IGX)(OTCQX: IGXT) and Tetra Bio-Pharma Inc. ("Tetra") (CSE: TBP)(OTC PINK: GRPOF), today announced the signing of a binding term sheet for the development and commercialization of a drug product containing dronabinol. Under the binding term sheet, Tetra will have exclusive rights to sell the product in North America with a right of first negotiation for outside the U.S. and Canada. The U.S. cancer pain market is expected to reach $5 billion in 2018.Per the Binding Term Sheet ...

09.02.2017


Page 1 from 89:  1 2  3  4  5  .. » 89





All members: 7 930
Register today: 1
Register yesterday: 1
Members online: 0
Guests online: 68


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.